International Assets Investment Management LLC Makes New $4.24 Million Investment in Encompass Health Co. (NYSE:EHC)

International Assets Investment Management LLC acquired a new stake in Encompass Health Co. (NYSE:EHC) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 43,883 shares of the company’s stock, valued at approximately $4,241,000.

A number of other hedge funds have also modified their holdings of the stock. Trillium Asset Management LLC acquired a new position in Encompass Health in the first quarter valued at about $4,432,000. TD Asset Management Inc grew its position in Encompass Health by 16.0% during the 1st quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock worth $188,586,000 after acquiring an additional 314,488 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in Encompass Health by 275.7% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock valued at $3,071,000 after purchasing an additional 26,270 shares in the last quarter. QRG Capital Management Inc. raised its position in Encompass Health by 85.6% in the 2nd quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock valued at $1,232,000 after purchasing an additional 6,627 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in Encompass Health in the second quarter worth $2,204,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Down 0.6 %

NYSE:EHC opened at $98.88 on Friday. The stock’s fifty day simple moving average is $94.47 and its 200-day simple moving average is $88.82. The firm has a market capitalization of $9.95 billion, a P/E ratio of 23.88, a P/E/G ratio of 1.47 and a beta of 0.88. The company has a quick ratio of 1.35, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 12-month low of $62.58 and a 12-month high of $102.36.

Encompass Health (NYSE:EHC) last posted its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The company’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.86 EPS. Equities research analysts expect that Encompass Health Co. will post 4.27 earnings per share for the current year.

Encompass Health declared that its board has authorized a stock buyback plan on Wednesday, July 24th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 5.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Insider Transactions at Encompass Health

In related news, CFO Douglas E. Coltharp sold 12,260 shares of the firm’s stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the sale, the chief financial officer now owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on EHC shares. Leerink Partnrs upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Wednesday, July 10th. UBS Group upped their target price on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. KeyCorp raised their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday. Truist Financial reaffirmed a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a report on Wednesday. Finally, Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $107.11.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.